Chronic Reduction in Paraventricular Nucleus (PVN) AT1R Expression by AAV‐mediated Transfer of a Small Hairpin RNA (shrna) Produces a Decrease in Blood Pressure in Spontaneously Hypertensive Rats

Zhiying Shan,Peng Shi,Ying Dong,Fan Lin,Gwyneth Lamont,Adolfo E. Cuadra,Qiuhong Li,Colin Sumners,Mohan K. Raizada
DOI: https://doi.org/10.1096/fasebj.25.1_supplement.1027.7
2011-01-01
Abstract:The PVN is a critical relay point in the CNS mechanisms that control sympathetic outflow and ultimately cardiovascular function. Ang II acting via AT1R in the PVN, increases blood pressure, and increased levels of AT1R in the PVN have been implicated in the establishment of hypertension. This led us to hypothesize that chronic inhibition of AT1R in this area would attenuate the development of hypertension. We tested this hypothesis with the use of an AAV-AT1R-shRNA vector to knockdown AT1R in the PVN. First, the effectiveness of the AT1R-shRNA was tested using primary neuronal cultures from SHR hypothalamus. Quantitative RT- PCR demonstrated that AT1R-shRNA treatment decreased AT1R mRNA levels by 72%, and completely diminished Ang II-induced stimulation of neuronal action potential frequency and Ang II induced ERK1/2 phosphorylation. Bilateral microinjection of AAV-AT1R-shRNA into the PVN of 8 week old SHR resulted in a significant decrease in mean arterial pressure (MAP). For example, at 5 weeks following the vector microinjections MAP was 133.8±4.5 mm Hg in the AT1R-shRNA treated rats and 144.2±3.8 mmHg in the control vector (scrambled shRNA)-treated rats, as indicated by telemetry recordings (p< 0.05). This decrease in MAP was associated with 36% decrease in the AT1R mRNA in the PVN. These observations demonstrate that AT1R in the PVN participate in the long-term control of neurogenic hypertension.
What problem does this paper attempt to address?